Package 61958-2005-1

{"route": ["ORAL"], "spl_id": "12aff732-63cd-4d90-a329-7c3851e6b966", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["FWF6Q91TZO", "G70B4ETF4S"], "rxcui": ["1747691", "1747697", "2590641", "2590643"], "spl_set_id": ["06f66e98-e6ee-4538-9506-6c1282cc14c1"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2005-1)", "package_ndc": "61958-2005-1", "marketing_start_date": "20220107"}], "brand_name": "DESCOVY", "product_id": "61958-2005_12aff732-63cd-4d90-a329-7c3851e6b966", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "61958-2005", "generic_name": "emtricitabine and tenofovir alafenamide", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DESCOVY", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "120 mg/1"}, {"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "15 mg/1"}], "application_number": "NDA208215", "marketing_category": "NDA", "marketing_start_date": "20220107", "listing_expiration_date": "20261231"}